Robert L. Elliott
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 7
-
- Infrared Thermography in Medicine 12
- Hematology top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 6
- Genetics top 10%
-
- Immunotherapy and Immune Responses 11
-
- Thermography and Photoacoustic Techniques 9
-
- Mitochondrial Function and Pathology 9
- RNA modifications and cancer 8
-
- Thermoregulation and physiological responses 8
- Partner nations
- United StatesItalySaudi Arabia
In The Last Decade
Robert L. Elliott
79 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 297
- Radiology, Nuclear Medicine and Imaging 440
- Hematology 173
- Oncology 414
- Genetics 129
Countries citing papers authored by Robert L. Elliott
This map shows the geographic impact of Robert L. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Elliott more than expected).
Fields of papers citing papers by Robert L. Elliott
This network shows the impact of papers produced by Robert L. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Elliott. The network helps show where Robert L. Elliott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert L. Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 80 | |
| 2 | 2020 | 35 | |
| 3 | 2019 | 16 | |
| 4 | 2016 | 3 | |
| 5 | 2015 | 1 | |
| 6 | 2013 | 15 | |
| 7 | 2012 | 48 | |
| 8 | 2012 | 110 | |
| 9 | 2011 | 40 | |
| 10 | Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. | 2010 | 78 |
| 11 | 2010 | 10 | |
| 12 | 2009 | 18 | |
| 13 | 2009 | 15 | |
| 14 | 2006 | 134 | |
| 15 | Phase II trial of Ontak to deplete regulatory T cells in treatment-refractory stage III/IV ovarian cancer | 2006 | 1 |
| 16 | 2006 | 5 | |
| 17 | 2002 | 23 | |
| 18 | Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. | 2000 | 54 |
| 19 | 1993 | 63 | |
| 20 | 1993 | 80 |
About Robert L. Elliott
Robert L. Elliott is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 84 papers that have together received 1.9k indexed citations. Recurring topics across this work include Infrared Thermography in Medicine (12 papers), Immunotherapy and Immune Responses (11 papers), Thermography and Photoacoustic Techniques (9 papers), Mitochondrial Function and Pathology (9 papers), RNA modifications and cancer (8 papers), Thermoregulation and physiological responses (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (297 citations), Radiology, Nuclear Medicine and Imaging (440 citations) and Hematology (173 citations). Robert L. Elliott has collaborated with scholars based in United States, Italy and Saudi Arabia. Frequent co-authors include Jonathan F. Head, Xian Jiang, Ding Yang, Fen Wang, Fen Wang, J. L. McCoy, Brian Barnett, Hairong Qi, W.E. Snyder and Fei Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.